| Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data (NCT06229405) | Seoul National University Hospital | 2022-05-10 |
| A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL (NCT05883085) | Peking Union Medical College Hospital | 2022-05-01 |
| Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death (NCT05446779) | Helsinki University Central Hospital | 2022-02-03 |
| Genetic Factors and Pheochromocytomas in Neoplasia Type 2 (NCT05158712) | Assistance Publique Hopitaux De Marseille | 2022-02-02 |
| 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor (NCT05069220) | Peking Union Medical College Hospital | 2021-09-01 |
| China Adrenal Disease Registry (NCT04890444) | Shanghai Jiao Tong University School of Medicine | 2021-06-01 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (NCT04400474) | Grupo Espanol de Tumores Neuroendocrinos | 2020-10-07 |
| Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents (NCT03923257) | Sue O'Dorisio | 2020-08-04 |
| Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis (NCT04557072) | Jagiellonian University | 2020-08-01 |
| Metanephrines in Obstructive Sleep Apnoea (NCT05053685) | Changi General Hospital | 2020-07-29 |
| A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (NCT04187404) | Enterome | 2020-07-23 |
| Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) (NCT04605848) | University of Avignon | 2020-07-03 |
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. (NCT04276597) | Excel Diagnostics and Nuclear Oncology Center | 2020-03-04 |
| Correlation Between Preoperative Images of PPGL and Intraoperative Hemodynamics (NCT06669481) | Peking Union Medical College Hospital | 2020-01-01 |
| Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease (NCT04891081) | University Medical Centre Ljubljana | 2019-11-01 |
| Cryoablation of Bone Metastases From Endocrine Tumors (NCT03986593) | Instituto do Cancer do Estado de São Paulo | 2019-09-26 |
| the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma (NCT04320589) | National Cancer Institute, Egypt | 2019-06-30 |
| LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) (NCT03946527) | Antonio Fojo | 2019-06-17 |
| 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma (NCT03541720) | St. Jude Children's Research Hospital | 2019-04-30 |
| Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma (NCT03839498) | Columbia University | 2019-01-22 |
| Cardiac and Vascular Changes in Pheochromocytoma and Paraganglioma (NCT05082311) | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 2019-01-19 |
| Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions (NCT04071561) | University of Basel | 2018-11-19 |
| A Prospective Cohort Study for Patients With Adrenal Diseases (NCT03474237) | Seoul National University Hospital | 2018-10-01 |
| DOTATOC PET/CT for Imaging NET Patients (NCT03583528) | British Columbia Cancer Agency | 2018-07-11 |
| Multicenter Pheochromocytoma and Paraganglioma Evaluation (NCT03344016) | Felix Beuschlein | 2017-11-01 |
| Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma (NCT03206060) | National Cancer Institute (NCI) | 2017-10-10 |
| F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma (NCT05948137) | Asan Medical Center | 2017-09-21 |
| A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer (NCT03165721) | National Cancer Institute (NCI) | 2017-08-16 |
| Surgeon-Anesthesiologist Collaboration (NCT03158870) | Hospices Civils de Lyon | 2017-07-01 |
| Preoperative Alpha Blockade for Pheochromocytoma (NCT03176693) | University of California, Los Angeles | 2017-05-05 |
| Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma (NCT06062082) | Central Hospital, Nancy, France | 2015-09-01 |
| Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study (NCT02618694) | Suez Canal University | 2015-04-01 |
| Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma (NCT01967576) | National Cancer Institute (NCI) | 2013-10-19 |
| Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue (NCT01949714) | University of Aarhus | 2013-08-01 |
| Dexmedetomidine Infusion During Laparoscopic Adrenalectomy (NCT06037135) | Yonsei University | 2012-12-03 |
| Phenoxybenzamine Versus Doxazosin in PCC Patients (NCT01379898) | University Medical Center Groningen | 2011-12-01 |
| Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma (NCT01425710) | Medical University of Vienna | 2011-08-01 |
| Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease (NCT00970970) | University Medical Center Groningen | 2009-09-01 |
| A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma (NCT00874614) | Molecular Insight Pharmaceuticals, Inc. | 2009-06-04 |
| A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... (NCT00923481) | National Cancer Institute (NCI) | 2009-04-01 |
| Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma (NCT00911729) | Molecular Insight Pharmaceuticals, Inc. | 2009-04-01 |
| Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma (NCT00843037) | University Health Network, Toronto | 2009-02-01 |
| Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma (NCT01022515) | University Hospital, Rouen | 2008-11-01 |
| RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid (NCT01152827) | Seoul National University Hospital | 2008-07-01 |
| Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma (NCT00458952) | Molecular Insight Pharmaceuticals, Inc. | 2007-04-01 |
| Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma (NCT00107289) | Memorial Sloan Kettering Cancer Center | 2006-05-01 |
| Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy (NCT01959711) | Jagiellonian University | 2006-01-01 |
| Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers (NCT00188019) | University Hospital, Angers | 2005-11-01 |
| Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions (NCT03160274) | The University of Texas Health Science Center at San Antonio | 2005-10-19 |
| Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma (NCT00126412) | GE Healthcare | 2005-08-02 |
| Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors (NCT00466856) | Vanderbilt-Ingram Cancer Center | 2003-12-01 |
| Pheochromocytoma and Hemodynamic Instability (NCT04566406) | Jagiellonian University | 2003-01-01 |
| Adrenal Tumors - Pathogenesis and Therapy (NCT00669266) | University of Wuerzburg | 2002-09-01 |
| Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors (NCT00049023) | O'Dorisio, M S | 2002-01-01 |
| 131MIBG to Treat Malignant Pheochromocytoma (NCT00028106) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2001-12-05 |
| Diagnosis of Pheochromocytoma (NCT00004847) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2000-03-22 |
| Blood Sampling for Neurochemical and Genetic Testing (NCT00001147) | National Institute of Neurological Disorders and Stroke (NINDS) | 1999-10-01 |
| Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer (NCT00002947) | Yale University | 1996-10-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma (NCT00002764) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-04-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma (NCT00002641) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-02-01 |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors (NCT00002608) | Ottawa Regional Cancer Centre | 1994-05-01 |
| A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors (NCT01413503) | University of California, San Francisco | 1991-05-01 |
| Diagnosis and Treatment of Pheochromocytoma (NCT00001229) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-10-01 |
| 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors (NCT01373736) | Vancouver Coastal Health | |
| A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma (NCT03015844) | Northwell Health | |
| Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma (NCT02961491) | Molecular Insight Pharmaceuticals, Inc. | |
| Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma (NCT01838187) | Children's Hospital Medical Center, Cincinnati | |
| Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma (NCT01377532) | University of California, San Francisco | |
| Expanded Access Protocol Using 131I-MIBG (NCT01590680) | Jubilant DraxImage Inc. | |